GetTopicDetailResponse(id=681112624577, topicName=可切除非小細(xì)胞肺癌, introduction=, content=可切除非小細(xì)胞肺癌, image=null, comments=0, allHits=65, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Tue Apr 22 17:00:29 CST 2025, time=2025-04-22, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=480561, tagList=[TagDto(tagId=480561, tagName=可切除非小細(xì)胞肺癌)], ipAttribution=, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2261560, encodeId=fe9022615600c, content=<a href='/topic/show?id=681112624577' target=_blank style='color:#2F92EE;'>#可切除非小細(xì)胞肺癌#</a>, objectTitle=再添新證！納武利尤單抗注射液新適應(yīng)癥獲批， 為中國(guó)可切除非小細(xì)胞肺癌患者帶來生存新突破, objectType=article, longId=872723, objectId=e12d8e272320, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241114/1731577202553_8538692.png, objectUrl=/article/show_article.do?id=e12d8e272320, replyNumber=0, likeNumber=19, createdTime=2025-04-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e12d8e272320, moduleTitle=再添新證！納武利尤單抗注射液新適應(yīng)癥獲批， 為中國(guó)可切除非小細(xì)胞肺癌患者帶來生存新突破, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e12d8e272320)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-04-22
